QHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations Program
QHSLab Inc. (OTCQB: USAQ), a digital health company focused on personalized medicine through population health screening and point of care diagnostic tools, has announced the engagement of Hayden IR to enhance its investor relations strategy and market visibility.
The company aims to strengthen its relationships with the investment community through Hayden IR's comprehensive services, which include investor management, relationship building, and awareness campaigns. Hayden IR, with offices in New York, Phoenix, and Dallas, has over two decades of experience supporting micro- and small-cap companies.
QHSLab reports significant progress in expanding its digital health solutions and provider network over the past year. The company's strategy focuses on leveraging data-driven tools to improve patient outcomes while enhancing healthcare provider efficiency.
QHSLab Inc. (OTCQB: USAQ), un'azienda di salute digitale focalizzata sulla medicina personalizzata tramite screening della salute della popolazione e strumenti diagnostici a punto di cura, ha annunciato l'ingaggio di Hayden IR per migliorare la sua strategia di relazioni con gli investitori e la visibilità sul mercato.
L'azienda mira a rafforzare le sue relazioni con la comunità degli investitori attraverso i servizi completi di Hayden IR, che includono gestione degli investitori, costruzione di relazioni e campagne di sensibilizzazione. Hayden IR, con uffici a New York, Phoenix e Dallas, vanta oltre due decenni di esperienza nel supporto di aziende micro e small-cap.
QHSLab riporta progressi significativi nell'espansione delle sue soluzioni di salute digitale e della rete di fornitori nell'ultimo anno. La strategia dell'azienda si concentra sull'utilizzo di strumenti basati sui dati per migliorare i risultati dei pazienti, incrementando al contempo l'efficienza dei fornitori di assistenza sanitaria.
QHSLab Inc. (OTCQB: USAQ), una empresa de salud digital centrada en la medicina personalizada a través del cribado de salud poblacional y herramientas de diagnóstico en el punto de atención, ha anunciado la contratación de Hayden IR para mejorar su estrategia de relaciones con inversores y visibilidad en el mercado.
La empresa tiene como objetivo fortalecer sus relaciones con la comunidad inversora a través de los servicios integrales de Hayden IR, que incluyen gestión de inversores, construcción de relaciones y campañas de concienciación. Hayden IR, con oficinas en Nueva York, Phoenix y Dallas, cuenta con más de dos décadas de experiencia apoyando a empresas micro y small-cap.
QHSLab informa de avances significativos en la expansión de sus soluciones de salud digital y su red de proveedores en el último año. La estrategia de la empresa se centra en aprovechar herramientas basadas en datos para mejorar los resultados de los pacientes, al mismo tiempo que se aumenta la eficiencia de los proveedores de atención médica.
QHSLab Inc. (OTCQB: USAQ)는 인구 건강 스크리닝 및 진료소 진단 도구를 통한 개인화된 의학에 중점을 둔 디지털 건강 회사로, 투자자 관계 전략과 시장 가시성을 향상시키기 위해 Hayden IR을 고용했다고 발표했습니다.
회사는 Hayden IR의 포괄적인 서비스를 통해 투자자 커뮤니티와의 관계를 강화하는 것을 목표로 하고 있으며, 여기에는 투자자 관리, 관계 구축 및 인식 캠페인이 포함됩니다. 뉴욕, 피닉스, 댈러스에 사무소를 둔 Hayden IR은 마이크로 및 소형 기업을 지원하는 데 20년 이상의 경험을 보유하고 있습니다.
QHSLab은 지난 1년 동안 디지털 건강 솔루션과 공급자 네트워크 확장에서 중요한 진전을 보고하고 있습니다. 회사의 전략은 데이터 기반 도구를 활용하여 환자 결과를 개선하고 의료 제공자의 효율성을 높이는 데 중점을 두고 있습니다.
QHSLab Inc. (OTCQB: USAQ), une entreprise de santé numérique axée sur la médecine personnalisée à travers le dépistage de la santé de la population et des outils de diagnostic au point de soin, a annoncé l'engagement de Hayden IR pour améliorer sa stratégie de relations avec les investisseurs et sa visibilité sur le marché.
L'entreprise vise à renforcer ses relations avec la communauté des investisseurs grâce aux services complets de Hayden IR, qui comprennent la gestion des investisseurs, le développement de relations et des campagnes de sensibilisation. Hayden IR, avec des bureaux à New York, Phoenix et Dallas, possède plus de deux décennies d'expérience dans le soutien aux entreprises micro et small-cap.
QHSLab fait état de progrès significatifs dans l'expansion de ses solutions de santé numérique et de son réseau de fournisseurs au cours de l'année écoulée. La stratégie de l'entreprise se concentre sur l'utilisation d'outils basés sur les données pour améliorer les résultats des patients tout en augmentant l'efficacité des prestataires de soins de santé.
QHSLab Inc. (OTCQB: USAQ), ein digitales Gesundheitsunternehmen, das sich auf personalisierte Medizin durch Bevölkerungs-Screenings und diagnostische Werkzeuge vor Ort konzentriert, hat die Zusammenarbeit mit Hayden IR bekannt gegeben, um seine Strategie für die Beziehungen zu Investoren und die Marktpräsenz zu verbessern.
Das Unternehmen zielt darauf ab, seine Beziehungen zur Investmentgemeinschaft durch die umfassenden Dienstleistungen von Hayden IR zu stärken, die Investorenmanagement, Beziehungsaufbau und Sensibilisierungskampagnen umfassen. Hayden IR hat Büros in New York, Phoenix und Dallas und verfügt über mehr als zwanzig Jahre Erfahrung in der Unterstützung von Mikro- und Small-Cap-Unternehmen.
QHSLab berichtet von erheblichen Fortschritten bei der Erweiterung seiner digitalen Gesundheitslösungen und des Anbieternetzwerks im vergangenen Jahr. Die Strategie des Unternehmens konzentriert sich darauf, datengestützte Werkzeuge zu nutzen, um die Ergebnisse für Patienten zu verbessern und gleichzeitig die Effizienz der Gesundheitsdienstleister zu steigern.
- Expanding digital health solutions portfolio
- Growing provider network
- Enhanced market visibility through professional IR firm
- Strengthening market position
- Trading on OTCQB market indicates smaller market capitalization
- Additional expenses from new IR engagement
WEST PALM BEACH, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing personalized medicine through innovative population health screening and point of care diagnostic tools in primary care, today announced it has engaged Hayden IR, a highly recognized national investor relations firm, to raise its visibility and strengthen its relationships with the investment community.
Troy Grogan, President and CEO of QHSLab, “Over the past year, we have made significant strides in expanding our suite of digital health solutions, growing our provider network and strengthening our market position. As we continue to drive innovation and scale our business, we have engaged the professionals at Hayden IR to help us reach a broader investor audience and effectively communicate our strategy and achievements.”
With offices in New York, Phoenix, and Dallas, Hayden IR provides a comprehensive range of investor relations services to a growing list of clients. For more than two decades, Hayden IR has been a recognized leader in driving market recognition and creating sustainable competitive advantages for more than 150 micro- and small-cap companies. Hayden delivers expertise and professionalism in such areas as investor management, relationship building, awareness campaigns, online presence and corporate identity.
Brett Maas, Managing Principal of Hayden IR, “QHSLab has developed an impressive portfolio of digital health solutions that address critical gaps in primary care. Their strategy is focused on leveraging data-driven tools to improve patient outcomes while enhancing efficiency for healthcare providers. The company is well-positioned to capitalize on a sizable market opportunity, and we look forward to assisting them in telling their story to a broader investor audience.”
For more information about QHSLab and our healthcare solutions, please visit www.qhslab.com.
About QHSLab, Inc.
QHSLab, Inc. (OTCQB: USAQ) is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. Digital healthcare allows doctors to assess patient responses quickly and effectively using advanced artificial intelligence algorithms. Digital healthcare can also remotely monitor patients’ vital signs and evaluate the effects of prescribed medicines and treatments on patients’ health through real-time data transferred from patient to doctor. QHSLab, Inc. also markets and sells point-of-care, rapid-response diagnostic tests used in the primary care practice. QHSLab, Inc.’s products and services are designed to help physicians improve patient monitoring and medical care while also increasing their revenues.
Forward-Looking Statements
Certain matters discussed in this press release are ‘forward-looking statements’ intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace, future revenues, future products, and potential future results and acquisitions are examples of such forward-looking statements. Forward-looking statements are generally identified by words such as ‘may,’ ‘could,’ ‘believes,’ ‘estimates,’ ‘targets,’ ‘expects,’ or ‘intends,’ and other similar words that express risks and uncertainties. These statements are subject to numerous risks and uncertainties, including, but not limited to, the timing of the introduction of new products, the inherent discrepancy in actual results from estimates, projections, and forecasts made by management, regulatory delays, changes in government funding and budgets, and other factors, including general economic conditions, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release. The Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
Investor Relations Contact:
Brett Maas, Managing Principal, Hayden IR, LLC
brett@haydenir.com
646-536-7331
https://twitter.com/QHSLabInc
FAQ
What is the purpose of QHSLab (USAQ) engaging Hayden IR?
What services will Hayden IR provide to QHSLab (USAQ)?
What recent developments has QHSLab (USAQ) reported in their digital health business?
How does QHSLab (USAQ) plan to improve healthcare delivery?
